Cleared Traditional

K883600 - EPSTEIN-BARR VIRUS (EBNA-1) IGG CATA. #4550

K883600 is an FDA 510(k) clearance for EPSTEIN-BARR VIRUS (EBNA-1) IGG CATA. #4550, manufactured by Clinical Sciences, Inc.. The device is a Class 1 Microbiology device with product code LLM cleared through the Traditional 510(k) pathway after a 261-day FDA review.

K883600 · Clinical Sciences, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1989
Decision
261d
Days
Class 1
Risk

K883600 is an FDA 510(k) clearance for the EPSTEIN-BARR VIRUS (EBNA-1) IGG CATA. #4550. Classified as Test, Antigen, Nuclear, Epstein-barr Virus (product code LLM), Class I - General Controls.

Submitted by Clinical Sciences, Inc. (Whippany, US). The FDA issued a Cleared decision on May 11, 1989 after a review of 261 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3235 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Clinical Sciences, Inc. devices

FDA 510(k) Submission Details - K883600

510(k) Number K883600 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 23, 1988
Decision Date May 11, 1989
Days to Decision 261 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
159d slower than avg
Panel avg: 102d · This submission: 261d
Pathway characteristics
Predicate-based equivalence.

LLM Device Classification - Class 1, General Controls

Product Code LLM Test, Antigen, Nuclear, Epstein-barr Virus
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3235
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LLM Test, Antigen, Nuclear, Epstein-barr Virus

All 21
Devices cleared under the same product code (LLM) and FDA review panel - the closest regulatory comparables to K883600.
EBNA ANTIBODY TEST SYSTEM (IMMUNOFLUORESCENT ANTI)
K895708 · Immuno Concepts, Inc. · Dec 1989
EBNA ANTIBODY TEST SYSTEM (IMMUNOENZYME ANTIBODY)
K895707 · Immuno Concepts, Inc. · Dec 1989
EBNA-CHECK(TM) TEST KIT
K891542 · Diagnostic Technology, Inc. · Jun 1989
EPSTEIN-BARR VIRUS (EBNA-1) IGM CATA. #5550
K883601 · Clinical Sciences, Inc. · May 1989
EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN ANTIBODY TEST
K882440 · Zeus Scientific, Inc. · Dec 1988
DU PONT EBNA-IGG ANTIBODY ELISA KIT
K875203 · E.I. Dupont DE Nemours & Co., Inc. · Aug 1988